PET imaging of CXCR4 receptors in cancer by a new optimized ligand. - Wikidata - wikimedia - TriplyDB

PET imaging of CXCR4 receptors in cancer by a new optimized ligand.

PET imaging of CXCR4 receptors in cancer by a new optimized ligand.

http://www.wikidata.org/entity/Q39502623

about

CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma Response assessment with the CXCR4-directed positron emission tomography tracer [68Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities Small molecule inhibitors of CXCR4.The intricate role of CXCR4 in cancer.Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.Prospective Study of (68)Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and First Application in Glioma Patients.[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experience Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo - a comparison to [(68)Ga]pentixafor.Multimodality imaging of CXCR4 in cancer: current status towards clinical translation.Comparison of (18)F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression.Prospective of ⁶⁸Ga-radiopharmaceutical development.[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values.Al[18F]NOTA-T140 Peptide for Noninvasive Visualization of CXCR4 Expression.FDG-PET imaging in hematological malignancies Novel Noninvasive Nuclear Medicine Imaging Techniques for Cardiac Inflammation.CXCR4-based imaging agents.Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4).Differential Expression of Chemokine Receptors and their Roles in Cancer Imaging.Imaging agents for the chemokine receptor 4 (CXCR4).Molecular imaging of chemokine receptor CXCR4.Molecular imaging probes derived from natural peptides.Synthesis and evaluation of an (18)F-labeled pyrimidine-pyridine amine for targeting CXCR4 receptors in gliomas.The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity.[177Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent.11C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions.(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.A conformationally frozen peptoid boosts CXCR4 affinity and anti-HIV activity.Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed Theranostics.Targeting CXCR4 with [68Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?Radiotheranostics in Cancer Diagnosis and Management.68Ga-Pentixafor PET/CT demonstrating higher CXCR4 density in small cell lung carcinoma than in non-small cell variant.Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.Upregulated myocardial CXCR4-expression after myocardial infarction assessed by simultaneous GA-68 pentixafor PET/MRI.Prospective of 68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation.Imaging of chemokine receptor CXCR4 expression in culprit and nonculprit coronary atherosclerotic plaque using motion-corrected [Ga]pentixafor PET/CT CXCR4-directed theranostics in oncology and inflammation

P2860

Q33703097-2F1C0ABD-8A2B-40B5-ADAF-9D18DAD8CCB0 Q33758646-1B971033-7A37-49B9-B9F2-6A79DC23170F Q34574987-0854A38A-2F3E-4475-9DA1-4C57FD61B88F Q35067624-454EA8B3-4D99-4ADA-9091-B879D9C6ACB9 Q35227508-25AF9629-B615-4E4E-9BDF-63CA4BD84BD3 Q35483867-90D3B377-C5F8-40C8-A9B1-945DC7D750BE Q35633357-7545C02B-E7CD-417A-B057-A564C1EC1A3E Q36962582-B1A0CC77-508E-4404-949C-755B2C36E8E1 Q37140477-F9E74E84-3644-41E9-B069-1B3845692A08 Q37273212-3E5DAD36-5A92-4034-BDDC-2223E6C7FC08 Q37337280-2B8FA614-E7B3-4C35-BE8B-1D8E3846CBAE Q37393337-96B93D01-4FA0-4FBC-AFC9-C83A28F8E707 Q37435222-8968BC83-68B7-49C1-874D-068E278F051B Q37541868-230849CA-8184-459F-ADF4-C77B22558A99 Q37592059-B5A2C53B-D898-4DC4-8F7E-C8C2B03486C8 Q37632114-5B39F629-9073-4CD6-AE5C-ED3D9F3078F8 Q37703212-D36EF0B7-6BFA-416C-8D58-DD4798CDDC0B Q37951878-A2DC6ADA-0212-4823-8A37-16EBEBEFC6D0 Q38003847-6AA8ED40-F6E6-4A68-ADF4-36AF17EE5AAA Q38015856-EE11FE86-85CD-4169-978B-1A1D262D4957 Q38022430-9E4F6DD6-3EDD-4093-931F-8BEBBF491409 Q38079238-B51BF130-D74F-4BD2-9727-A0CE797A2F24 Q38748846-7211483A-614B-4319-A612-8269154A9625 Q38754142-B80378BE-1DBE-486A-A7FF-1CC41DDC25C4 Q38876206-3538DCE2-06A6-429E-97AF-66ADAD07C94A Q41114242-5E1D75EB-52E4-4374-B379-AE26CE930AC8 Q41455546-74AE6C2B-B94B-4FE5-8C77-C6F262AFDB01 Q42545669-49AF76EB-8382-4119-A0A3-801DBF7DCC95 Q44612728-0185F12D-105B-4812-9F17-34F0C3872854 Q47114899-3D34B7EE-E90C-46AE-AF99-277893480D54 Q47159998-C6DFC628-66D2-4C4E-B90D-482CCD5E665F Q47719762-3F4C4699-0972-4458-A413-708B278A42C6 Q52954408-6C4E1091-D60E-4066-B2F7-C783BC32FC55 Q52983236-A3EC29F7-C3AA-4D61-9F5C-C900CBB1FF92 Q52986842-DB4EEF80-8492-40BC-AFA7-3684AF6E1F00 Q54257268-F201CC8D-B13F-4705-9A66-7C27B0B52248 Q57138035-4BF60303-3385-4866-A061-04BCF2D50453 Q58783862-255CF6F4-00E6-4900-B564-7F400D46EF2C

P2860

PET imaging of CXCR4 receptors in cancer by a new optimized ligand.

http://www.wikidata.org/entity/Q39502623

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

PET imaging of CXCR4 receptors in cancer by a new optimized ligand.

@en

PET imaging of CXCR4 receptors in cancer by a new optimized ligand.

@nl

type

label

PET imaging of CXCR4 receptors in cancer by a new optimized ligand.

@en

PET imaging of CXCR4 receptors in cancer by a new optimized ligand.

@nl

prefLabel

PET imaging of CXCR4 receptors in cancer by a new optimized ligand.

@en

PET imaging of CXCR4 receptors in cancer by a new optimized ligand.

@nl

P1433

Q39502623-209F82A8-67E9-4283-8C4D-214CA64821D1

P1476

Q39502623-BC04B8E0-9149-4AE2-AA71-D3C50727AC5E

P2093

Q39502623-3ED768A5-39F2-4954-BB72-717830160D48

Q39502623-43F659F4-F190-4279-8195-BD70176AC5D8

Q39502623-4A04C916-1ED6-4AF3-84CF-55F19B77A950

Q39502623-85AAFE7E-994F-471F-99C6-F14E2EFC3C81

Q39502623-CFE3C855-B4E6-4E67-8570-3E8C28267E4A

P2860

Q39502623-03D92BDC-37C5-4DEF-A435-BCD3A4AD1F0D

Q39502623-14BED692-FF46-4DEE-A29C-2862057FD83F

Q39502623-17BDBE8B-5FF3-41A2-BACB-B0950EB55367

Q39502623-1A27906E-C8FB-4E1D-B7D8-A05E87AF8F5F

Q39502623-1FB29ECB-B9E5-48AE-9699-B6B2383C9F43

Q39502623-215F5227-407A-496A-8524-7883184D36C3

Q39502623-2905FB16-5714-4D0E-BEEC-11ECA1237597

Q39502623-29E00319-F14B-4A0D-A368-CE13E3C696DC

Q39502623-2A66598F-3D83-49DD-A997-1F847F47395E

Q39502623-398C735E-9854-459A-A529-C0D926F56818

P304

Q39502623-95ED052C-9FC4-4A99-952F-4268B2986245

P31

Q39502623-F20F4F39-3642-43AE-A21B-F16A1CC330FE

P356

Q39502623-D6713527-F6FD-47C3-9262-F4C916775220

P433

Q39502623-BF75BFE1-49A2-4C3D-BBAC-8AEC19A3D882

P478

Q39502623-8C800D95-2726-48CF-BCD1-05AD557FC410

P577

Q39502623-99650190-14BB-4DE3-846A-A6B46E51FFFB

P5875

Q39502623-A2271F78-2F04-4029-A998-73AF84CC82F7

P698

Q39502623-6823078C-05FD-4F9F-BD87-0F19F32A600F

P932

Q39502623-E8C3C8ED-F476-41AE-B787-805B4F8EEFDF

P356

P1433

P1476

PET imaging of CXCR4 receptors in cancer by a new optimized ligand.

@en

P2093

Eleni Gourni

http://www.w3.org/2001/XMLSchema#string

Hans-Jürgen Wester

http://www.w3.org/2001/XMLSchema#string

Horst Kessler

http://www.w3.org/2001/XMLSchema#string

Oliver Demmer

http://www.w3.org/2001/XMLSchema#string

Udo Schumacher

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer and the chemokine network

A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II)

Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100

Molecular imaging: current status and emerging strategies.

A systematic review of PET and PET/CT in oncology: a way to personalize cancer treatment in a cost-effective manner?

Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds.

Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based libraries.

Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities.

Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.

Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT

P304

1789-1791

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201100320

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51512696

http://www.w3.org/2001/XMLSchema#string

P698

21780290

http://www.w3.org/2001/XMLSchema#string

P932

3229844

http://www.w3.org/2001/XMLSchema#string